From injection to inhalation: A STING‐activating mucosal adjuvant reprograms vaccination
Open Access
- 25 August 2026
- journal article
- invited letter
- Published by Wiley in Clinical and Translational Medicine
- Vol. 16 (9) , e70798
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (92369112)
- National Natural Science Foundation of China (82574418)
This publication has 5 references indexed in Scilit:
- Intranasal gold nanoparticle-antigen induces mucosal and systemic immunity against β-coronaviruseshLife, 2026
- Regional immunity in the respiratory tract: challenges and opportunitiesScience Bulletin, 2026
- Linking vaccine adjuvant mechanisms of action to functionScience Immunology, 2025
- Neutralization of SARS-CoV-2 BA.2.86 and JN.1 by CF501 adjuvant-enhanced immune responses targeting the conserved epitopes in ancestral RBDCell Reports Medicine, 2024
- A pan-sarbecovirus vaccine based on RBD of SARS-CoV-2 original strain elicits potent neutralizing antibodies against XBB in non-human primatesProceedings of the National Academy of Sciences, 2023